Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Metastatic Castration-resistant Prostate Cancer × bempegaldesleukin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Advanced Cancer 1

Interventions

Nivolumab 2 radium Ra 223 dichloride 1 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 darolutamide 1 bempegaldesleukin 1 Radium-223 1 Radiosurgery 1 Cyclophosphamide 1 Blood Specimen Collection 1 177Lu-EB-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03835533 2024-04-12

PORTER

Parker Institute for Cancer Immunotherapy

Phase 1 Completed

43 enrolled 19 charts

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡